5-Demethoxyfumagillol, a potent angiogenesis inhibitor isolated from Aspergillus fumigatus

Chemical and Pharmaceutical Bulletin

Volumn 52, Issue 4, 2004, Pages 447-450

  Kim, Deukjoon ^a   Min, Jaeki ^a   Ahn, Soon Kil ^b   Lee, Hong Woo ^b   Choi, Nam Song ^b   Moon, Seung Kee ^b  

^a Seoul National University   (South Korea)

^b Chong Kun Dang Research Institute   (South Korea)

Author keywords

5 demethoxyfumagillol; Angiogenesis inhibitor; Aspergillus fumigatus; Fermentation; Semi synthetic fumagillol derivative

Indexed keywords

5 DEMETHOXYFUMAGILLOL; 6 O (CHLOROACETYLCARBAMOYL) 5 DEMETHOXYFUMAGILLOL; ANGIOGENESIS INHIBITOR; FUMAGILLOL; UNCLASSIFIED DRUG; 5-DEMETHOXYFUMAGILLOL; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; SESQUITERPENE;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CELL STRAIN; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; DRUG PURIFICATION; DRUG STRUCTURE; IN VITRO STUDY; NONHUMAN; SAPONIFICATION; SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; ANIMAL; CATTLE; CELL DIVISION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ISOLATION AND PURIFICATION; PULMONARY ARTERY; TUMOR CELL LINE;

ANGIOGENESIS INHIBITORS; ANIMALS; ASPERGILLUS FUMIGATUS; CATTLE; CELL DIVISION; CELL LINE, TUMOR; ENDOTHELIAL CELLS; INDICATORS AND REAGENTS; PULMONARY ARTERY; SESQUITERPENES;

EID: 4444263991     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.52.447     Document Type: Article

References (22)

1. Billington D. C., Drug Des. Discov., 8, 3-35 (1991).
2. Folkman J., N. Eng. J. Med., 285, 1182-1186 (1971).
3. Hanson F. R., Eble T. E., J. Bacteriol., 58, 527-529 (1949).
4. McCorkindale N. J., Sime J. G., Proc. Chem. Soc., 1961, 331 (1961).
5. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamara T., Brem H., Folkman J., Nature (London), 348, 555-557 (1990).
6. Folkman J., Ingber D. E., Cancer Biol., 3, 89-96 (1992).
7. Ingber D. E., Cancer Biol., 3, 57-63 (1992).
8. Folkman J., J. Natl. Cancer Inst., 82, 4-6 (1990).
9. Taylor S., Folkman J., Nature (London), 297, 307-312 (1982).
10. Folkman J., Adv. Cancer Res., 43, 175-203 (1985).
11. Stadler W. M., Kuzel T., Shapiro C., Sosman J., Clark J., Vogelzang N. J., J. Clin. Oncol., 17, 2541-2545 (1999).
12. Zgodzinski W., Wallner G., Dabrowski A., Pol. J. Pharmacol., 51, 455-462 (1999).
13. Moore J. D., Dezube J., Gill P., Zhou X. J., Acosta E. P., Sommadossi J. P., Cancer Chem., 46, 173-179 (2000).
14. Kruger E. A., Figg W. D., Expert Opin. Investig. Drugs, 9, 1383-1396 (2000).
15. Choi N. S., Lee S. J., Ahn S. K., Chun H. S., Hong R. K., Kim J. W., Lee H. W., Moon S. K., Hong C. I., W. O. Patent 99/59987 (1999).
16. Tarbell D. S., Hoffman P., Al-Kazani R., Page G. A., Ross J. M., Vogt H. R., Wargotz B., J. Am. Chem. Soc., 77, 5610-5617 (1955).
17. Molander G. A., Hahn G., J. Org. Chem., 51, 1135-1138 (1986).
18. Folkman J., Ingber D. E., Ann. Surg., 206, 374-383 (1987).
19. Oikawa T., Hirotani K., Nakamura O., Shudo K., Iwaguchi T., Cancer Lett., 48, 157-162 (1989).
20. Langer R., Brem H., Falterman K., Klein M., Folkman J., Science, 193, 70-72 (1976).
21. Marui S., Itoh F., Kozai Y., Sudo K., Kishimoto S., Chem. Pharm. Bull., 40, 96-101 (1992).
22. Still W., Kahn M., Mitra A., J. Org. Chem., 43, 2923-2925 (1978).